- Home
- IVD
- By Technology Types
- By Diseases Types
- By Product Types
- Research
- Resource
- Distributors
- Company
| Product Name | Anti-Programmed Death-Ligand 1 (PD-L1) Antibody |
| Catalog No. | RDMA-0308 |
| Description | High-performance recombinant antibody targeting CD274 (PD-L1), essential for evaluating T-cell exhaustion and immune regulation in chronic rheumatic diseases. |
| Category | SLE Marker |
| Host Species | Rabbit |
| Clonality | Recombinant |
| Isotype | IgG |
| Form | Liquid |
| Concentration | 1.1 mg/mL |
| Purity | >99% |
| Purification | Affinity |
| Buffer | 10mM PBS |
| Preservative | None |
| Application | ELISA/CLIA |
| Matching Antigen | Recombinant PD-L1 |
| Sensitivity | Ultra-High |
| Specificity | No PD-L2 cross |
| CV (%) | <3% |
| Storage | 2-8°C |
| Shelf Life | 24 Months |
| Stability | 5x Cycles |
| Titer | 1:1.4M |
| Protein Test | UV280 |
| Endotoxin | <0.5 EU/mg |
For research use only, not for clinical use.
|
There is no product in your cart. |
Copyright © 2026 Alta DiagenoTech. All rights reserved.
